Article
Genomic Landscape of Primary Tumor Site and Clinical Outcome for Patients with Metastatic Colorectal Cancer Receiving Standard-of-Care Chemotherapy.
Targeted oncology - 1 May 2022
Mizukami Takuro, Takahashi Masaki, Sunakawa Yu, Yuki Satoshi, Kagawa Yoshinori, Takashima Atsuo, Kato Kyoko, Hara Hiroki, Denda Tadamichi, Yamamoto Yoshiyuki, Shiozawa Manabu, Oki Eiji, Okamoto Wataru, Yoshino Takayuki, Eguchi Nakajima Takako
Abstract excerpt
BACKGROUND: Primary tumor site and genomic status are utilized for regimen selection in metastatic colorectal cancer; however, the impact on clinical practice is not well known. OBJECTIVE: We aimed to clarify the impact of primary tumor site and genomic status on clinical practice in metastatic colorectal cancer. METHODS: The relationship between primary tumor site, genomic alterations, and clinical outcomes was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
